Vertex Pharmaceuticals Incorporated (VRTX)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
96.71-4.28 (-4.24%)
At close: 4:00 PM EDT
People also watch:
ALXNREGNBMRNBIIBINCY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open101.20
Prev Close100.99
Bid93.78 x 100
Ask99.70 x 100
Day's Range96.27 - 102.49
52wk Range75.90 - 136.97
1y Target EstN/A
Market Cap23.96B
P/E Ratio (ttm)-85.28
Beta1.54
Volume1,327,378
Avg Vol (3m)1,399,609
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Why no other drug maker was able to close the Medivation deal
    Nicole Sinclair2 days ago

    Why no other drug maker was able to close the Medivation deal

    On Monday, Medivation (MDVN), which owns Xtandi, confirmed it was being acquired by Pfizer (PFE) for $14 billion. This comes just months after Sanofi (SNY) approached Medivation in a hostile deal, going public with its offer and beginning a process to replace the company’s board. Sanofi lost out on its bid to Pfizer, which was willing to pay up and fold Medivation into its oncology franchise.

  • Pfizer-Medivation Deal Reignites Biotech Buyout Speculation
    Investor's Business Daily2 days ago

    Pfizer-Medivation Deal Reignites Biotech Buyout Speculation

    Pfizer's Medivation buyout agreement has put an M&A spotlight on BioMarin, Incyte, Vertex and other drug companies.

  • P-s-s-st! Here's What Fidelity Has Been Buying And Selling
    Investor's Business Daily6 days ago

    P-s-s-st! Here's What Fidelity Has Been Buying And Selling

    Would it help your portfolio to know what Fidelity's 200 stock and stock-plus-bond mutual funds bought and sold in Q2?